Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity

Sophia Eilat-Tsanania Department of Family Medicine, Clalit Health Services, North District, Israel;b Department of Family Medicine, Azrieli Faculty of Medicine, Bar-Ilan University, Ramat Gan, Israel;c Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, CanadaView further author information

Pierre Ernstc Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, Canada;d Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, CanadaView further author information

Samy Suissac Centre for Clinical Epidemiology, Lady Davis Institute-Jewish General Hospital, Montreal, Canada;d Department of Epidemiology and Biostatistics, and of Medicine, McGill University, Montreal, CanadaCorrespondence[email protected]
View further author information

Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Real-World Effectiveness of Single-Inhaler Triple Therapy for COPD: Impact of Diabetes Comorbidity

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date